Specific markers representing the differentiation stages of AML were matched to the data reported in the original article, including mature molecules such as FCN1 and CD14 and early markers such as CRIP1 and NPW (Fig. 7a) [14]. Here, CRIP1 is linked to acute myeloid leukemia.